Targeted Therapies

There are specific drugs able to attack specific abnormalities within breast cancer cells:

Trastuzumab (Herceptin) Some breast cancers have too much human growth factor 2 (HER2). This drug targets this protein that aids in the growth and survival of breast cancer cells.

Side Effects

  • Heart damage
  • Headaches
  • Skin rashes

Lapatinib (Tykerb) This drug is used for women with advanced metastatic breast cancer who already have tried trastuzumab but yet the cancer still progressed.

Side Effects

  • Nausea and vomiting
  • Diarrhea
  • Fatigue
  • Mouth sores
  • Skin rashes
  • Painful hands and feet

Bevacizumab (Avastin) In certain situations this drug can be recommended, it stops cancer cells from attracting new blood vessels to the cancer cell, which bring oxygen and nutrients to the tumor. This results in cancer cell death.

Side Effects

  • Fatigue
  • High blood pressure
  • Mouth sores
  • Skin rashes
  • Painful hands and feet

Spotlight

Hear from Dr. Anil Sood, the Foundation’s Research Chairman, and Carol Brown, 2014 SGO Program Chair, about research of interest to women and the public presented at the 2014 SGO Annual Meeting on Women’s Cancer. Watch the video

Awareness

A new SGO Clinical Practice Statement states women diagnosed with epithelial ovarian, tubal, and peritoneal cancers should be considered for genetic counseling and testing, even in the absence of a family history.

Education

The next Gynecologic Cancer Survivors Course Friday, May 2, 2014 in Long Island, NY. For more information on courses, click here.